
UroGen Pharma a Stock to Sell After Its Chief Medical Officer Unloaded 5,222 Shares?
UroGen Pharma's chief medical officer Mark Schoenberg sold 5,222 ordinary shares for about $143,000, disclosed in an SEC Form 4. The sale followed the exercise of 10,000 options, with a weighted...
























































:max_bytes(150000):strip_icc()/sore-neck-56b0100e5f9b58b7d02002cf.jpg)




